← Back to Search

Hormone Therapy

Hormone Supplement for Polycystic Ovary Syndrome

N/A

Waitlist Available

Research Sponsored by Rael

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to week 12

Awards & highlights

Study Summary

This trial tests a female hormone balance supplement for 12 weeks. Participants take 1 scoop daily and answer questionnaires at various times.

Who is the study for?

This trial is for women aged 18-55 who are generally healthy with a BMI under 35. It's aimed at those experiencing hormonal skin issues, irregular menstrual cycles, mood swings, stress, irritability, low energy or symptoms of PCOS like irregular periods. Pregnant or breastfeeding women and those with chronic diseases that could interfere with the study can't participate.Check my eligibility

What is being tested?

The study tests a Female Hormone Balance Supplement taken daily for 12 weeks to see if it helps with Polycystic Ovary Syndrome (PCOS) and severe Premenstrual Syndrome (PMS). Participants will mix one scoop of the supplement in their drink each morning and complete questionnaires over the course period.See study design

What are the potential side effects?

Potential side effects aren't specified but may include reactions typical to supplements such as digestive discomfort, allergic reactions or changes in hormone levels which could affect mood and energy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in hormonal acne.

Changes in menstrual cycle regularity.

Changes in skin issues throughout the menstrual cycle.

Secondary outcome measures

Changes in energy.

Changes in food cravings.

Changes in menstrual cramps.

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Female Hormone Balance SupplementExperimental Treatment1 Intervention

Participants will add 1 scoop of the powder to a drink of choice every morning.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor

68 Previous Clinical Trials

3,805 Total Patients Enrolled

5 Trials studying Premenstrual Syndrome

268 Patients Enrolled for Premenstrual Syndrome

RaelLead Sponsor

3 Previous Clinical Trials

120 Total Patients Enrolled

1 Trials studying Premenstrual Syndrome

40 Patients Enrolled for Premenstrual Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants over the age of 35?

"This experiment is open to adults aged 18 and over, but not exceeding 55 years old."

Answered by AI

Do I satisfy the prerequisites to join this clinical research?

"Eligibility criteria for this trial necessitates that patients must have polycystic ovary syndrome and be aged between 18-55. The research team is recruiting a total of 40 participants."

Answered by AI

Is there currently a recruitment phase for this research endeavor?

"The information hosted on clinicaltrials.gov indicates that this study is not recruiting patients at the moment. This trial was initiated and last revised in August and November of 2023, respectively; however there are currently 1567 other studies actively seeking participants."

Answered by AI

What are the primary goals of this medical research study?

"The primary efficacy endpoint evaluated over a 12-week period is the reduction of hormonal acne, while secondary endpoints include changes in stress levels (measured with 5-point Likert scale surveys), food cravings and energy."

Answered by AI